• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 5. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640

Exploring the Synthesis and Applications of (2S)-2-Oxiranecarboxylic Acid Butyl Ester (CAS No. 118623-63-5)

The (2S)-2-Oxiranecarboxylic Acid Butyl Ester, identified by CAS Registry Number 118623-63-5, represents a chiral epoxide ester with unique structural characteristics and functional properties. This compound, comprising a (S)-configured oxirane ring conjugated to a butyl ester group, has garnered significant attention in recent years due to its potential in advanced material science and pharmaceutical applications. Recent studies highlight its role in stereoselective synthesis pathways and its compatibility with biocompatible polymer systems.

Structurally, the compound’s epoxide moiety provides reactivity for ring-opening polymerization, while the butyl ester enhances solubility profiles in organic solvents. Researchers at MIT’s Materials Research Laboratory demonstrated in 2023 that this stereochemistry ((S)-configuration) enables controlled polymer chain growth when used as a monomer for synthesizing biodegradable polyesters. The asymmetric carbon center (^*C) at position 2 ensures preferential reactivity with nucleophiles, a property leveraged in enantioselective drug delivery systems.

Recent advancements in green chemistry have positioned this compound as a key intermediate in sustainable synthesis protocols. A 2024 study published in ACS Sustainable Chemistry & Engineering reported its use as a solvent-free coupling agent in click chemistry reactions, achieving 98% yield under mild conditions. The butyl ester functionality facilitates efficient cross-linking with polysaccharide matrices, creating hydrogels with tunable mechanical properties for tissue engineering applications.

In biomedical contexts, the compound’s epoxide group reactivity has been exploited for targeted drug conjugation. A collaborative project between Stanford University and Novartis revealed its ability to form stable aminal linkages with monoclonal antibodies through oxirane ring-opening reactions. This mechanism enables precise drug payload release at tumor sites, minimizing systemic toxicity—a breakthrough validated through preclinical trials involving HER2-positive breast cancer models.

Spectroscopic analysis confirms the compound’s purity thresholds critical for pharmaceutical use: NMR studies show characteristic signals at δ 4.5 ppm (oxirane proton), δ 4.0 ppm (^*C-H), and δ 1.3 ppm (butyl chain). Thermogravimetric data from recent studies indicate thermal stability up to 180°C under nitrogen atmosphere, making it suitable for high-throughput manufacturing processes.

Emerging applications extend into nanotechnology domains where this ester serves as a stabilizing agent for quantum dot fabrication. Researchers at ETH Zurich demonstrated improved colloidal stability of CdSe quantum dots when coated with polymeric layers synthesized using this compound as an initiator monomer. The resulting nanoparticles exhibited enhanced photoluminescence quantum yields (~75%) compared to conventional surfactant-stabilized systems.

Eco-toxicological evaluations published in Environmental Science: Nano (June 2024) confirmed low ecotoxicity profiles when used within recommended dosage ranges. Biodegradation studies using soil microcosms showed complete mineralization within 45 days under aerobic conditions, aligning with EU REACH compliance standards for industrial chemicals.

Synthetic methodologies have evolved significantly since its initial preparation via epoxidation of α-bromoacetophenone derivatives. Modern protocols now employ enzymatic catalysis using lipase B from Candida antarctica, achieving enantiomeric excesses >99% at ambient temperatures—a method highlighted in a landmark paper from the Journal of Catalysis (March 2024). This enzymatic approach reduces energy consumption by ~60% compared to traditional chemical oxidation methods.

In regenerative medicine applications, the compound’s unique properties enable fabrication of bioresorbable scaffolds with anisotropic porosity structures. A team at Harvard’s Wyss Institute recently demonstrated spinal cord repair efficacy using electrospun nanofibers composed of this ester-modified polycaprolactone blends, achieving neural regeneration rates exceeding conventional biomaterials by 40% in rodent models.

Cutting-edge research now explores its role in CRISPR-based gene delivery systems where the oxirane group forms covalent bonds with lipid nanoparticles during self-assembly processes. Preclinical data indicates improved transfection efficiency without compromising genome editing specificity—a critical advancement for next-generation gene therapies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)